Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome after Allogeneic Stem Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network Protocol
Author:
Funder
National Heart, Lung, and Blood Institute
National Cancer Institute
Leukemia and Lymphoma Society
Burroughs Welcome Fund
Publisher
Elsevier BV
Subject
Transplantation,Hematology
Reference17 articles.
1. Idiopathic pneumonia after bone marrow transplantation: cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment;Clark;Crit Care Med,1999
2. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation;Kantrow;Transplantation,1997
3. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease;Chien;Biol Blood Marrow Transplant,2010
4. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation;Shannon;Bone Marrow Transplant,2010
5. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation;Clark;Am Rev Respir Dis,1993
Cited by 74 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Noninfectious Pulmonary Complications;The EBMT Handbook;2024
2. Miscellaneous Complications of Hematopoietic Cellular Transplantation;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024
3. Long-term survival of a pediatric hematopoietic cell transplant recipient with Fanconi anemia treated with extracorporeal membrane oxygenation: Case report and review of the literature;Pediatric Hematology Oncology Journal;2023-12
4. Diffuse Alveolar Hemorrhage in Hematopoietic Cell Transplantation;Journal of Intensive Care Medicine;2023-10-23
5. Respiratory Failure Due to Idiopathic Pneumonia Syndrome in a Pediatric Patient After Recipient-derived Allogeneic Chimeric Antigen Receptor T-Cell Therapy;Journal of Pediatric Hematology/Oncology;2023-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3